title: Direct-to-consumer genomic testing offers little clinical utility but appears to cause minimal harm.
abstract: Direct-to-consumer genomic testing is available to anyone willing to pay for it. We investigated the reliability and reproducibility of such testing by sending DNA samples to 2 popular companies and by reviewing current literature on this topic. The concerns that were initially raised about direct-to- consumer genomic testing still seem valid.
authors: Corresponding author: Arthur S. Aylesworth, University of North Carolina at Chapel Hill, CB 7487, Chapel Hill, NC 27599, USA. asayls@med.unc.edu.
authors: Stacie D
authors: SD
authors: Adams
authors: James P
authors: JP
authors: Evans
authors: Arthur S
authors: AS
authors: Aylsworth
mesh_terms: D005820:Genetic Testing; D006801:Humans; D010358:Patient Participation; D015203:Reproducibility of Results; D018570:Risk Assessment